{
   "sha": "fa0eaef225e1bfa0aa470be4c089ae0689193fec",
   "source_x": "PMC",
   "title": "Emerging Infectious Diseases in 2012: 20\u00a0Years after the Institute of Medicine Report",
   "doi": "http://dx.doi.org/10.1128/mBio.00494-12",
   "pmcid": "PMC3520107",
   "pubmed_id": "23232716",
   "license": "CC BY-NC-SA",
   "abstract": "Twenty\u00a0years ago (1992), a landmark Institute of Medicine report entitled \u201cEmerging Infections: Microbial Threats to Health in the United States\u201d underscored the important but often underappreciated concept of emerging infectious diseases (EIDs). A review of the progress made and setbacks experienced over the past 2 decades suggests that even though many new diseases have emerged, such as SARS (severe acute respiratory syndrome) and the 2009 pandemic influenza, significant advances have occurred in EID control, prevention, and treatment. Among many elements of the increase in the capacity to control EIDs are genomics-associated advances in microbial detection and treatment, improved disease surveillance, and greater awareness of EIDs and the complicated variables that underlie emergence. In looking back over the past 20\u00a0years, it is apparent that we are in a time of great change in which both the challenge of EIDs and our responses to them are being transformed. Recent advances support guarded optimism that further breakthroughs lie ahead.",
   "publish_time": "2012 Dec 11",
   "authors": [
      "['Morens, David M.', 'Fauci, Anthony S.']"
   ],
   "journal": "mBio",
   "has_full_text": "True",
   "id": "fa0eaef225e1bfa0aa470be4c089ae0689193fec",
   "fhir_link": "Non-comercial/fa0eaef225e1bfa0aa470be4c089ae0689193fec"
}